Scarica l'app Stockscreener
30.35
3.97%
-1.2251
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$31.58
Aprire:
$31.58
Volume 24 ore:
143.42K
Relative Volume:
0.21
Capitalizzazione di mercato:
$544.76M
Reddito:
$116.88M
Utile/perdita netta:
$-25.09M
Rapporto P/E:
-216.82
EPS:
-0.14
Flusso di cassa netto:
$-20.74M
1 W Prestazione:
+2.52%
1M Prestazione:
+6.26%
6M Prestazione:
+56.64%
1 anno Prestazione:
+113.57%
Intervallo 1D:
$30.16
$31.70
Intervallo di 1 settimana:
$29.14
$32.90
Portata 52W:
$13.91
$43.72
Rigel Pharmaceuticals Stock (RIGL) Company Profile
Nome
Rigel Pharmaceuticals
Settore
Industria
Telefono
650-624-1100
Indirizzo
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Confronta RIGL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
30.37 | 566.46M | 116.88M | -25.09M | -20.74M | -0.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.60 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.72 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.82 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.12 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-04-03 | Ripresa | Piper Sandler | Neutral |
| 2022-06-09 | Downgrade | Citigroup | Buy → Neutral |
| 2022-06-08 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-03-23 | Iniziato | B. Riley Securities | Neutral |
| 2020-11-09 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-11-15 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-09-26 | Ripresa | JP Morgan | Overweight |
| 2019-03-01 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-08-27 | Iniziato | Citigroup | Buy |
| 2018-05-02 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-12-21 | Ripresa | Piper Jaffray | Overweight |
| 2017-12-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-11-06 | Ripresa | H.C. Wainwright | Buy |
| 2017-03-09 | Reiterato | H.C. Wainwright | Buy |
| 2016-08-31 | Reiterato | H.C. Wainwright | Buy |
| 2016-08-30 | Reiterato | Piper Jaffray | Overweight |
| 2016-07-13 | Iniziato | H.C. Wainwright | Buy |
| 2016-06-13 | Iniziato | Piper Jaffray | Overweight |
| 2016-04-22 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2013-04-08 | Reiterato | Stifel | Buy |
| 2012-11-29 | Iniziato | UBS | Neutral |
| 2012-11-06 | Reiterato | Oppenheimer | Outperform |
| 2012-03-26 | Iniziato | Canaccord Genuity | Hold |
| 2010-12-10 | Downgrade | MP Advisors | Outperform → Market Perform |
Mostra tutto
Rigel Pharmaceuticals Borsa (RIGL) Ultime notizie
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition - WV News
Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Report Preview: What to Expect - GuruFocus
Can you recover from losses in Rigel Pharmaceuticals Inc.2025 Investor Takeaways & Daily Technical Stock Forecast Reports - newser.com
Will Rigel Pharmaceuticals Inc. stock reach Wall Street targetsJuly 2025 Update & AI Powered Market Entry Strategies - newser.com
Can Rigel Pharmaceuticals Inc. (RI2) stock ride next bull market cyclePortfolio Value Summary & AI Forecasted Stock Moves - newser.com
Candlestick signals on Rigel Pharmaceuticals Inc. stock today2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Will Rigel Pharmaceuticals Inc. (RI2) stock outperform value peersJuly 2025 Action & Smart Allocation Stock Tips - newser.com
What insider trading reveals about Rigel Pharmaceuticals Inc. stock2025 Institutional Moves & Weekly Setup with High ROI Potential - newser.com
Detecting price anomalies in Rigel Pharmaceuticals Inc. with AI2025 Market Sentiment & Fast Entry High Yield Tips - newser.com
How Rigel Pharmaceuticals Inc. stock responds to policy changesAnalyst Upgrade & Short-Term High Return Strategies - newser.com
Is Rigel Pharmaceuticals Inc. stock a contrarian buyRate Cut & Expert Curated Trade Setup Alerts - newser.com
What momentum shifts mean for Rigel Pharmaceuticals Inc.July 2025 Analyst Calls & Safe Capital Growth Plans - newser.com
Why pension funds invest in Rigel Pharmaceuticals Inc. (RI2) stock2025 Risk Factors & Consistent Growth Equity Picks - newser.com
Why Rigel Pharmaceuticals Inc. stock remains undervaluedTrade Volume Report & Weekly Setup with ROI Potential - newser.com
Can Rigel Pharmaceuticals Inc. stock hit analyst price targetsQuarterly Performance Summary & Technical Buy Zone Confirmation - newser.com
Will earnings trigger a reversal in Rigel Pharmaceuticals Inc.Quarterly Trade Report & High Win Rate Trade Tips - newser.com
What machine learning models say about Rigel Pharmaceuticals Inc.July 2025 News Drivers & Verified Swing Trading Watchlist - newser.com
Can Rigel Pharmaceuticals Inc. stock deliver strong Q4 earnings2025 Sector Review & Safe Capital Preservation Plans - newser.com
Can a trend reversal in Rigel Pharmaceuticals Inc. lead to recoveryDollar Strength & Daily Profit Focused Screening - newser.com
Is Rigel Pharmaceuticals Inc. stock recession proofEarnings Beat & Verified High Yield Trade Plans - newser.com
Published on: 2025-11-02 12:30:33 - newser.com
Can machine learning forecast Rigel Pharmaceuticals Inc. recoveryMarket Performance Summary & Risk Controlled Swing Alerts - newser.com
Why Rigel Pharmaceuticals Inc. stock could see breakout soonWeekly Loss Report & AI Driven Price Predictions - newser.com
What is the fair value estimate for Rigel Pharmaceuticals Inc. (RI2) stock in 2025Earnings Overview Report & AI Powered Trade Plan Recommendations - newser.com
Measuring Rigel Pharmaceuticals Inc.’s beta against major indices2025 Macro Impact & Free Safe Capital Growth Stock Tips - newser.com
Will Rigel Pharmaceuticals Inc. (RI2) stock enhance shareholder valueLong Setup & Safe Capital Growth Stock Tips - newser.com
Rigel Pharmaceuticals Inc expected to post earnings of 85 cents a shareEarnings Preview - TradingView
Rigel Gears Up to Report Q3 Earnings: Here's What to Expect - sharewise.com
Rigel Pharmaceuticals Azioni (RIGL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.21%
0.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):